Financials VITA 34 AG

Equities

V3V

DE000A0BL849

Healthcare Facilities & Services

Market Closed - Xetra 11:36:24 2024-06-11 am EDT 5-day change 1st Jan Change
4.86 EUR 0.00% Intraday chart for VITA 34 AG -1.22% -7.25%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 52.07 51.43 239.8 123.8 82.94 84.72 - -
Enterprise Value (EV) 1 50.25 46.34 239 135.7 82.94 84.52 77.42 70.72
P/E ratio 38.6 x 33.9 x -23.8 x -4.57 x -43.7 x -60.8 x -243 x 122 x
Yield 1.25% - - - - - - -
Capitalization / Revenue 2.57 x 2.56 x 8.44 x 1.8 x 1.08 x 1.05 x 1.02 x 0.99 x
EV / Revenue 2.48 x 2.31 x 8.41 x 1.97 x 1.08 x 1.04 x 0.93 x 0.82 x
EV / EBITDA 8.75 x 7.99 x 294 x -38.1 x 14.9 x 12.4 x 9.33 x 7 x
EV / FCF 10.2 x 13.9 x 512 x -12.4 x - 17.6 x 10.9 x 10.4 x
FCF Yield 9.79% 7.2% 0.2% -8.05% - 5.68% 9.17% 9.62%
Price to Book 1.73 x 1.74 x 2.03 x 7.5 x - - - -
Nbr of stocks (in thousands) 4,084 4,098 15,989 15,828 15,828 17,432 - -
Reference price 2 12.75 12.55 15.00 7.820 5.240 4.860 4.860 4.860
Announcement Date 3/23/20 3/30/21 4/30/22 4/30/23 4/30/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 20.25 20.07 28.42 68.94 77.06 81 83.4 85.9
EBITDA 1 5.746 5.8 0.814 -3.564 5.569 6.8 8.3 10.1
EBIT 1 3.282 2.88 -3.071 -27.28 -3.12 -1.2 0.2 1.7
Operating Margin 16.21% 14.35% -10.81% -39.57% -4.05% -1.48% 0.24% 1.98%
Earnings before Tax (EBT) 1 3.142 2.27 -3.447 -28.29 -4.342 -2 -0.6 1
Net income 1 1.35 1.151 -3.667 -27.09 -1.865 -1.4 -0.4 0.7
Net margin 6.67% 5.74% -12.9% -39.29% -2.42% -1.73% -0.48% 0.81%
EPS 2 0.3300 0.3700 -0.6300 -1.710 -0.1200 -0.0800 -0.0200 0.0400
Free Cash Flow 1 4.918 3.335 0.467 -10.92 - 4.8 7.1 6.8
FCF margin 24.29% 16.62% 1.64% -15.84% - 5.93% 8.51% 7.92%
FCF Conversion (EBITDA) 85.59% 57.5% 57.37% - - 70.59% 85.54% 67.33%
FCF Conversion (Net income) 364.3% 289.75% - - - - - 971.43%
Dividend per Share 0.1600 - - - - - - -
Announcement Date 3/23/20 3/30/21 4/30/22 4/30/23 4/30/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 S1
Net sales 1 - 16.63 32.11
EBITDA 1 - -1.549 -2.613
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income -2.81 - -
Net margin - - -
EPS -0.1800 - -
Dividend per Share - - -
Announcement Date 5/31/22 8/30/22 8/30/22
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - 11.9 - - - -
Net Cash position 1 1.82 5.09 0.86 - - 0.2 7.3 14
Leverage (Debt/EBITDA) - - - -3.339 x - - - -
Free Cash Flow 1 4.92 3.34 0.47 -10.9 - 4.8 7.1 6.8
ROE (net income / shareholders' equity) 4.53% 4% -10.6% -90.9% - -6.1% -1.9% 3.3%
ROA (Net income/ Total Assets) 2.24% 1.96% -3.1% -16.4% - -0.9% -0.3% 0.5%
Assets 1 60.21 58.62 118.3 164.7 - 155.6 133.3 140
Book Value Per Share 7.360 7.210 7.400 1.040 - - - -
Cash Flow per Share - - - - - - - -
Capex 1 1.4 0.65 2.26 6.43 - 2 2.5 2.5
Capex / Sales 6.91% 3.21% 7.95% 9.33% - 2.47% 3% 2.91%
Announcement Date 3/23/20 3/30/21 4/30/22 4/30/23 4/30/24 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.86 EUR
Average target price
6 EUR
Spread / Average Target
+23.46%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. V3V Stock
  4. Financials VITA 34 AG